CEO Jamal Rushdy and new CFO Hilary Spence present a business overview and an update of the ChondroMimetic® clinical study.
Jamal Rushdy CEO introduction – 00:18
Regenerative medicine overview – 01:12
What Collagen Solutions does – 2:40
Core business model – 5:53
Revenue trend – 9:39
ChondroMimetic® introduction – 10:21
Knee cartilage disease progression - 12:28
Current treatments – 14:55
ChondroMimetic® clinical study – 17:35
Study highlights - 18:31
Study data introduction - 22:16
Study results - 23:51
Market opportunities – 28:03
Key competitive differentiators - 31:55
Conclusions & next steps – 33:30
Q&A – 35:25
Other uses of ChondroMimetic®? – 35:26
US Regulation? - 37:10
How long does the treatment last? - 39:47
Other geographical markets? - 41:28
Partnerships? - 42:34
Cashflow - 44:50
End - 46:42
.png)
